ISSN:
2181-3906
2025
International scientific journal
«MODERN
SCIENCE
АND RESEARCH»
VOLUME 4 / ISSUE 8 / UIF:8.2 / MODERNSCIENCE.UZ
279
ETIOLOGY OF MALABSORPTION SYNDROME AND PATHOMORPHOLOGICAL
CHANGES IN THE INTESTINE
Ortiqova Barchinoy
Student of Central Asian Medical University, Fergana City, Republic of Uzbekistan.
https://doi.org/10.5281/zenodo.16902194
Annotation. Malabsorption syndrome is a multifactorial clinical condition characterized
by impaired digestion and absorption of nutrients in the small intestine. The disorder may arise
from congenital enzyme deficiencies, chronic inflammatory diseases, pancreatic and
hepatobiliary dysfunction, infectious agents, or structural intestinal abnormalities.
Pathomorphological changes, such as villous atrophy, crypt hyperplasia, and
inflammatory infiltration of the mucosa, are central to its development and progression.
Clinically, malabsorption presents with both gastrointestinal symptoms, including chronic
diarrhea, abdominal discomfort, and steatorrhea, as well as systemic manifestations such as
anemia, bone demineralization, growth retardation, and neurological deficits. Diagnosis requires
an integrated approach, combining biochemical, radiological, endoscopic, and histopathological
evaluations.
Keywords: Malabsorption syndrome, Intraluminal digestion, Mucosal absorption,
Postmucosal transport, Villous atrophy, Crypt hyperplasia, Inflammatory infiltration,
Steatorrhea, Hypoproteinemia, Osteomalacia.
ЭТИОЛОГИЯ СИНДРОМА МАЛЬАБСОРБЦИИ И ПАТОМОРФОЛОГИЧЕСКИЕ
ИЗМЕНЕНИЯ КИШЕЧНИКА
Аннотация. Синдром мальабсорбции – это многофакторное клиническое
состояние, характеризующееся нарушением переваривания и всасывания питательных
веществ в тонком кишечнике. Заболевание может быть обусловлено врожденной
ферментной недостаточностью, хроническими воспалительными заболеваниями,
дисфункцией поджелудочной железы и гепатобилиарной системы, инфекционными
агентами или структурными аномалиями кишечника. Патоморфологические изменения,
такие как атрофия ворсинок, гиперплазия крипт и воспалительная инфильтрация
слизистой оболочки, играют ключевую роль в его развитии и прогрессировании.
Клинически мальабсорбция проявляется как желудочно-кишечными симптомами,
включая хроническую диарею, дискомфорт в животе и стеаторею, так и системными
проявлениями, такими как анемия, деминерализация костей, задержка роста и
неврологические нарушения. Диагностика требует комплексного подхода, сочетающего
биохимические,
рентгенологические,
эндоскопические
и
гистопатологические
исследования.
Ключевые слова: Синдром Мальабсорбции, Внутрипросветное Пищеварение,
Слизистая Абсорбция, Постмукозный Транспорт, Атрофия Ворсинок, Гиперплазия
Крипт, Воспалительная Инфильтрация, Стеаторея, Гипопротеинемия, Остеомаляция.
Introduction
Malabsorption syndrome is a pathological condition characterized by impaired digestion
and absorption of nutrients in the small intestine, leading to deficiencies of proteins, fats,
ISSN:
2181-3906
2025
International scientific journal
«MODERN
SCIENCE
АND RESEARCH»
VOLUME 4 / ISSUE 8 / UIF:8.2 / MODERNSCIENCE.UZ
280
carbohydrates, vitamins, and minerals. This disorder is not an independent disease but rather a
complex clinical manifestation that develops as a result of various gastrointestinal and systemic
pathologies. The etiology of malabsorption syndrome is diverse and includes congenital
enzymatic defects, chronic inflammatory bowel diseases, pancreatic insufficiency, celiac disease,
infections, and surgical resections of the intestine. The pathogenesis of malabsorption is closely
related to both functional and structural changes in the small intestine. Particularly,
morphological alterations in the intestinal mucosa such as villous atrophy, crypt hyperplasia,
inflammatory cell infiltration, and fibrosis play a crucial role in the impairment of absorption
processes. These pathological changes disrupt the surface area available for nutrient absorption,
alter enzymatic activity, and cause secondary systemic complications, including malnutrition,
anemia, osteoporosis, and growth retardation in children. Understanding the mechanisms of
malabsorption syndrome and its associated intestinal pathomorphological changes is essential for
timely diagnosis, effective treatment, and prevention of complications. Therefore, this topic
holds great importance in gastroenterology and internal medicine, requiring further research and
clinical attention.
Main part
Malabsorption syndrome is a pathological state resulting from impaired digestion and
absorption of nutrients in the small intestine. Normally, intestinal villi and microvilli ensure
efficient uptake of proteins, fats, carbohydrates, vitamins, and minerals, but in this condition, that
function is disturbed. It is not regarded as a single disease entity but rather as a clinical
manifestation of various disorders. Patients may present with symptoms ranging from mild
nutritional deficiency to severe systemic complications. The syndrome may occur acutely or
persist as a chronic disorder. Its general characteristics include weight loss, weakness, anemia,
and biochemical disturbances. Clinicians categorize malabsorption into intraluminal, mucosal,
and postmucosal types, depending on the primary mechanism involved. This classification
reflects the complexity of the disorder and emphasizes the importance of comprehensive
evaluation. In essence, malabsorption syndrome represents a multifactorial condition requiring
accurate diagnosis.
The causes of malabsorption syndrome are highly diverse and multifactorial. Congenital
etiologies include enzyme deficiencies such as lactase deficiency and rare genetic disorders
affecting transport systems. Acquired causes are more common and include chronic pancreatitis,
liver diseases, and celiac disease. Infections, particularly parasitic infestations like Giardia
lamblia, can also impair absorption. Surgical resection of large segments of the intestine, known
as short bowel syndrome, is another well-documented cause. Autoimmune processes, such as
those observed in inflammatory bowel disease, contribute to mucosal injury and subsequent
malabsorption. Other causes include bile acid deficiency, lymphatic obstruction, and radiation
enteropathy. Each of these mechanisms ultimately interferes with nutrient absorption. The
multifactorial nature of these causes necessitates individualized diagnostic approaches.
The pathogenesis of malabsorption involves a complex interplay between defective
digestion and impaired absorption. Intraluminal mechanisms include reduced enzyme activity
and bile salt deficiency, leading to incomplete breakdown of food. Mucosal mechanisms involve
damage to the epithelial lining, such as villous atrophy, crypt hyperplasia, or epithelial
ISSN:
2181-3906
2025
International scientific journal
«MODERN
SCIENCE
АND RESEARCH»
VOLUME 4 / ISSUE 8 / UIF:8.2 / MODERNSCIENCE.UZ
281
inflammation. Postmucosal mechanisms occur when absorbed nutrients cannot be transported
due to lymphatic obstruction or vascular compromise. Pathogenesis is further complicated by
alterations in the gut microbiota, which may exacerbate inflammation. These processes reduce
the absorptive surface area and impair enzyme activity, resulting in inadequate nutrient uptake.
Over time, persistent malabsorption causes secondary systemic effects such as
malnutrition, anemia, and metabolic bone disease. Understanding the pathogenesis provides a
framework for targeted therapeutic strategies.
Pathomorphological alterations in the small intestine are central to malabsorption
syndrome. The most characteristic feature is villous atrophy, which dramatically reduces
absorptive surface area. Crypt hyperplasia is often observed, indicating compensatory epithelial
regeneration. Inflammatory cell infiltration in the lamina propria contributes to tissue damage
and functional impairment. Fibrosis and scarring of the mucosa may develop in chronic cases,
further restricting nutrient absorption. In celiac disease, these changes are particularly prominent,
with complete flattening of villi. Infectious causes may produce mucosal erosions, edema, and
epithelial destruction. Pancreatic insufficiency, though primarily extraluminal, also leads to
secondary intestinal mucosal changes due to maldigestion. These histopathological findings are
crucial for establishing diagnosis and guiding therapy.
Clinical manifestations of malabsorption syndrome are highly variable but generally
reflect nutrient deficiencies. Gastrointestinal symptoms include chronic diarrhea, bloating,
abdominal pain, and steatorrhea. Systemic manifestations are more serious, including anemia
from iron, folate, or vitamin B12 deficiency. Fat-soluble vitamin deficiencies lead to
osteomalacia, rickets, and coagulopathy. Protein deficiency results in muscle wasting, edema,
and hypoalbuminemia. Children may present with growth retardation, delayed puberty, and
developmental delays. Neurological symptoms, such as peripheral neuropathy, are associated
with vitamin B12 or thiamine deficiency. In severe cases, patients develop cachexia and
profound metabolic disturbances. The multisystemic nature of clinical manifestations
underscores the need for comprehensive evaluation and treatment.
Diagnosis of malabsorption syndrome requires a stepwise and multidisciplinary
approach. Laboratory tests are essential for detecting anemia, hypoproteinemia, electrolyte
imbalances, and vitamin deficiencies. Stool analysis provides evidence of steatorrhea and
undigested food particles. Imaging studies, including abdominal ultrasound, CT, and MRI, can
reveal structural abnormalities. Endoscopic procedures with biopsy of the small intestine are
critical for assessing villous atrophy, crypt hyperplasia, and inflammatory infiltrates. Breath tests
are useful for detecting carbohydrate malabsorption and bacterial overgrowth. Pancreatic
function tests help identify exocrine insufficiency. Radiological contrast studies can demonstrate
intestinal shortening or structural lesions. Genetic testing may be indicated for congenital
enzyme deficiencies. Accurate diagnosis requires integration of clinical, biochemical,
radiological, and histological data.
Treatment of malabsorption syndrome is based on correcting the underlying cause and
addressing nutritional deficiencies. Conservative management includes dietary modification,
such as a gluten-free diet in celiac disease or lactose restriction in lactase deficiency. Pancreatic
enzyme replacement is used in exocrine pancreatic insufficiency.
ISSN:
2181-3906
2025
International scientific journal
«MODERN
SCIENCE
АND RESEARCH»
VOLUME 4 / ISSUE 8 / UIF:8.2 / MODERNSCIENCE.UZ
282
Vitamin and mineral supplementation is crucial, particularly fat-soluble vitamins, iron,
folate, and B12. Infections require specific antimicrobial therapy. Anti-inflammatory or
immunosuppressive drugs are indicated in autoimmune causes such as Crohn’s disease. In cases
of lymphatic obstruction, surgical or interventional procedures may be necessary. Nutritional
support, including enteral or parenteral nutrition, is used in severe cases. Regular monitoring
ensures prevention of long-term complications. An individualized, multidisciplinary approach is
essential for optimal management.
Prevention of malabsorption syndrome primarily depends on early recognition and
treatment of underlying diseases. Public health measures, such as controlling parasitic infections
and improving nutrition, reduce incidence. Patient education on dietary management plays a key
role, particularly for chronic conditions. Prognosis varies depending on the etiology: celiac
disease and lactose intolerance generally have excellent outcomes with dietary therapy, whereas
short bowel syndrome or chronic pancreatitis may carry a poorer prognosis. Delayed diagnosis
often results in severe malnutrition, growth failure, and long-term complications. Clinically,
malabsorption remains significant due to its systemic impact and potential for misdiagnosis.
Continued research into pathophysiology and novel treatments is essential for improving patient
outcomes.
Conclusion
Malabsorption syndrome represents a multifactorial clinical condition with profound
implications for patient health and quality of life. It arises from a wide range of congenital and
acquired causes, including enzymatic defects, chronic inflammatory diseases, pancreatic
insufficiency, intestinal resections, and infections. The underlying pathogenesis involves
disturbances in intraluminal digestion, mucosal absorption, and postmucosal transport, all of
which culminate in inadequate nutrient uptake. Pathomorphological changes, particularly villous
atrophy, crypt hyperplasia, and inflammatory infiltration of the mucosa, are hallmarks of the
disorder and play a central role in its progression. Clinically, the syndrome manifests through
both gastrointestinal and systemic features, ranging from diarrhea and steatorrhea to anemia,
bone disease, growth retardation, and neurological deficits. Diagnosis requires a comprehensive
approach, integrating biochemical, radiological, endoscopic, and histological findings. Treatment
strategies must be tailored to the underlying etiology, with emphasis on dietary modification,
enzyme replacement, vitamin and mineral supplementation, and management of complications.
Ultimately, early recognition and targeted management of malabsorption syndrome are crucial
for preventing long-term systemic consequences. Its significance in gastroenterology and internal
medicine highlights the necessity of continued research into its mechanisms, diagnostic
innovations, and therapeutic options. Through a multidisciplinary approach, patient outcomes
can be substantially improved, ensuring better quality of life and reduction of morbidity.
References
1.
Green, P.H.R., & Cellier, C. (2007). Celiac disease.
New England Journal of Medicine
,
357(17), 1731–1743.
ISSN:
2181-3906
2025
International scientific journal
«MODERN
SCIENCE
АND RESEARCH»
VOLUME 4 / ISSUE 8 / UIF:8.2 / MODERNSCIENCE.UZ
283
2.
Guandalini, S., & Vaziri, N.D. (2014). Malabsorption syndromes. In:
Sleisenger and
Fordtran’s Gastrointestinal and Liver Disease
(10th ed., pp. 1674–1692). Philadelphia:
Elsevier Saunders.
3.
Бекмуродова, У. Р., Жабборов, А. А., & Султонов, Н. Н. (2022). ОСОБЕННОСТИ
ТЕЧЕНИЯ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК У БОЛЬНЫХ, ПЕРЕНЕСШИХ
СОVID-19.
Oriental renaissance: Innovative, educational,
natural
and social
sciences
,
2
(6), 270-281.
4.
Di Sabatino, A., & Corazza, G.R. (2009). Coeliac disease.
Lancet
, 373(9673), 1480–1493.
5.
Джабборов, А. А. О. (2025, February). ОСОБЕННОСТИ ПОРАЖЕНИЯ
ПЕРИФЕРИЧЕСКОЙ НЕРВНОЙ СИСТЕМЫ У БОЛЬНЫХ САХАРНЫМ
ДИАБЕТОМ II ТИПА И АЛГОРИТМ ПРОФИЛАКТИКИ. In
Scientific Conference on
Multidisciplinary Studies
(pp. 158-164).
6.
Rubio-Tapia, A., Hill, I.D., Kelly, C.P., Calderwood, A.H., & Murray, J.A. (2013). ACG
clinical guidelines: diagnosis and management of celiac disease.
American Journal of
Gastroenterology
, 108(5), 656–676.
7.
Абдукадирова, Д. Т., Абдукадиров, У. Т., & Жабборов, А. А. (2022).
ДИАБЕТИЧЕСКАЯ ПОЛИНЕЙРОПАТИЯ: ПУТИ ПОЛНОЦЕННОЙ КОРРЕКЦИИ
НЕВРОЛОГИЧЕСКОГО ДЕФИЦИТА.
Новости образования: Исследование в XXI
веке
,
306
.
8.
Kliegman, R.M., St. Geme, J.W., Blum, N.J., Shah, S.S., Tasker, R.C., & Wilson, K.M.
(2020).
Nelson Textbook of Pediatrics
(21st ed.). Philadelphia: Elsevier.
